Suppr超能文献

基于治疗困扰、满意度和自我效能的日本2型糖尿病患者自我主导与医生主导胰岛素滴定比较:COMMIT-患者研究

Comparison of Patient-Led and Physician-Led Insulin Titration in Japanese Type 2 Diabetes Mellitus Patients Based on Treatment Distress, Satisfaction, and Self-Efficacy: The COMMIT-Patient Study.

作者信息

Ishii Hitoshi, Nakajima Hiroki, Kamei Nozomu, Uchida Daigaku, Suzuki Daisuke, Ono Yasuhiro, Sato Yasunori, Shimono Dai

机构信息

Department of Doctor-Patient Relationships, Nara Medical University, Kashihara, Nara, Japan.

Department of Diabetes and Endocrine Medicine, Nara Medical University, Kashihara, Nara, Japan.

出版信息

Diabetes Ther. 2021 Feb;12(2):595-611. doi: 10.1007/s13300-020-00995-8. Epub 2021 Jan 18.

Abstract

INTRODUCTION

In Japan, patient-led insulin titration is rare in type 2 diabetes mellitus (T2DM) patients. Few studies have compared the effects of patient-led versus physician-led insulin titration on patient-reported outcomes in Japanese T2DM patients. This study aimed to compare the effects of patient-led and physician-led insulin titration in Japanese insulin-naïve T2DM patients on safety, glycemic control, and patient-reported outcomes (emotional distress, treatment satisfaction, and self-efficacy).

METHODS

Ultimately, 125 insulin-naïve Japanese T2DM patients were randomly assigned to either a patient-led insulin self-titration group or a physician-led insulin titration group and monitored for 24 weeks. The primary endpoint was a change in emotional distress as measured using the Problem Areas in Diabetes scale (PAID). Secondary endpoints included treatment satisfaction, as measured with the Diabetes Treatment Satisfaction Questionnaire (DTSQ), self-efficacy as measured using the Insulin Therapy Self-Efficacy Scale (ITSS), glycated hemoglobin (HbA1c) levels, fasting plasma glucose levels, body weight, insulin daily dose, and frequency of hypoglycemia.

RESULTS

There was no significant difference between the groups in PAID and DTSQ scores. The results for the primary endpoint should be interpreted taking account that the sample size for the power calculation was not reached. ITSS scores were significantly higher in the patient-led self-titration group. HbA1c and fasting plasma glucose levels were significantly decreased in both groups, but the decrease was significantly larger in the patient-led self-titration group. Although the insulin daily dose was significantly higher in the patient-led self-titration group, severe hypoglycemia did not occur in either group, and the frequency of hypoglycemia was similar in both groups.

CONCLUSION

Self-measurement of blood glucose and self-titration of insulin enhanced the patients' self-efficacy without compromising their emotional distress or treatment satisfaction. Also, insulin self-titration was found to be safe and effective; it resulted in better glycemic control without severe hypoglycemia.

TRIAL REGISTRATION

University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) (registration number: UMIN000020316).

摘要

引言

在日本,2型糖尿病(T2DM)患者中由患者主导的胰岛素滴定很少见。很少有研究比较过在日本T2DM患者中,由患者主导与由医生主导的胰岛素滴定对患者报告结局的影响。本研究旨在比较在日本初治T2DM患者中,由患者主导和由医生主导的胰岛素滴定在安全性、血糖控制及患者报告结局(情绪困扰、治疗满意度和自我效能感)方面的影响。

方法

最终,125例初治的日本T2DM患者被随机分配至患者主导的胰岛素自我滴定组或医生主导的胰岛素滴定组,并接受24周的监测。主要终点是使用糖尿病问题领域量表(PAID)测量的情绪困扰变化。次要终点包括使用糖尿病治疗满意度问卷(DTSQ)测量的治疗满意度、使用胰岛素治疗自我效能量表(ITSS)测量的自我效能感、糖化血红蛋白(HbA1c)水平、空腹血糖水平、体重、每日胰岛素剂量及低血糖发生频率。

结果

两组在PAID和DTSQ评分上无显著差异。在考虑到未达到用于功效计算的样本量的情况下,应对主要终点结果进行解释。患者主导的自我滴定组的ITSS评分显著更高。两组的HbA1c和空腹血糖水平均显著降低,但患者主导的自我滴定组的降低幅度显著更大。虽然患者主导的自我滴定组的每日胰岛素剂量显著更高,但两组均未发生严重低血糖,且两组的低血糖发生频率相似。

结论

血糖自我测量和胰岛素自我滴定可增强患者的自我效能感,且不影响其情绪困扰或治疗满意度。此外,发现胰岛素自我滴定是安全有效的;它能在不发生严重低血糖的情况下实现更好的血糖控制。

试验注册

大学医院医学信息网络临床试验注册中心(UMIN-CTR)(注册号:UMIN000020316)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77ce/7846626/2b1bf60e7245/13300_2020_995_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验